Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-12Clinical Trial Update: Lifestyle MIND- Feasibility of Wait-list Control [NA]
A feasibility trial of a Lifestyle MIND intervention for individuals with Type 2 diabetes mellitus and serious mental illness (including sch…
-
CLINICAL_TRIALS withdrawal · 2026-02-27Clinical Trial Update: Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease [NA]
A probiotic clinical trial investigating Type 2 diabetes mellitus and chronic obstructive pulmonary disease was terminated.
-
CLINICAL_TRIALS withdrawal · 2026-02-25Clinical Trial Update: A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM [Phase 2]
Phase 2 study evaluating HT-6184 in combination with semaglutide for obese participants with type 2 diabetes has been withdrawn.
-
EMA withdrawal · 2026-02-05EMA Withdrawn: Lyxumia (lixisenatide) — Sanofi Winthrop Industrie
The European Medicines Agency has withdrawn Lyxumia (lixisenatide) from the market; the decision was made on 27 August 2024.
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD) [Phase 3]
Phase 3 trial TRIAD evaluating an investigational SGLT2 inhibitor in combination with an investigational DPP-4 inhibitor for type 2 diabetes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin [Phase 3]
A Phase III trial evaluating a fixed-dose combination of an SGLT2 inhibitor with a thiazolidinedione for type 2 diabetes patients on metform…
-
EMA withdrawal · 2025-11-13EMA Lapsed: Sitagliptin / Metformin hydrochloride Accord (metformin hydrochloride;sitagliptin hydrochloride monohydrate) — Accord Healthcare S.L.U.
The European Medicines Agency notes that Accord Healthcare's sitagliptin/metformin hydrochloride combination product has lapsed its marketin…
-
CLINICAL_TRIALS withdrawal · 2025-11-06Clinical Trial Update: Detection of Diffuse Scar in Patients With Diabetes [Phase 4]
A Phase 4 clinical trial examining detection of diffuse scar in patients with Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-24Clinical Trial Update: A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes [Phase 2]
A Phase 2 trial evaluating bimagrumab and tirzepatide, alone or in combination, in adults with obesity or overweight with Type 2 diabetes, h…
-
CLINICAL_TRIALS withdrawal · 2025-09-22Clinical Trial Update: Type 2 Diabetes Post Exercise Arterial Stiffness [NA]
A clinical trial studying post-exercise arterial stiffness in individuals with Type 2 Diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-19Clinical Trial Update: A Lifestyle Change Program for Managing Diabetes [NA]
A clinical trial evaluating a lifestyle change program for Type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-15Clinical Trial Update: Mobilizing Doulas to Empower Black Women in Post-partum Diabetes Prevention [NA]
This clinical trial update notes that the study on mobilizing doulas to empower Black women in post-partum diabetes prevention has been with…
-
CLINICAL_TRIALS withdrawal · 2025-08-11Clinical Trial Update: HEART Kitchen Pilot [NA]
The HEART Kitchen Pilot trial has been withdrawn, with no results or ongoing data reported in this update. No drug data or efficacy results …
-
CLINICAL_TRIALS withdrawal · 2025-07-10Clinical Trial Update: Community-based CBT and T2D in Latino Population [NA]
A community-based cognitive behavioral therapy trial for adults with Type 2 Diabetes in the Latino population has been withdrawn from the cl…
-
CLINICAL_TRIALS withdrawal · 2025-07-01Clinical Trial Update: Plant-Based Dietary Intervention in Type 2 Diabetes-2 [NA]
A clinical trial evaluating a plant-based dietary intervention for Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: Effect of a Dietary Intervention on Intracellular Lipid Levels, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes [NA]
A clinical trial evaluating a dietary intervention for effects on intracellular lipid levels, insulin sensitivity, and glycemic control in T…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Diabetes Mellitus
A non-interventional pilot study sponsored by ProgenaBiome to explore the role of gut flora in diabetes mellitus, including Type 2 diabetes …
-
CLINICAL_TRIALS withdrawal · 2025-06-03Clinical Trial Update: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes [NA]
A clinical trial evaluating next-generation sensors and algorithms for diabetes management has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-29Clinical Trial Update: Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes [Phase 1]
Phase 1 trial evaluating Bardoxolone methyl in chronic kidney disease and type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-29Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis [Phase 2]
A Phase 2 double-blind, randomized, placebo-controlled safety trial evaluating the effects of residual renal function in patients with end-s…
-
CLINICAL_TRIALS withdrawal · 2025-05-29Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus [Phase 2]
The phase 2 randomized trial of bardoxolone methyl in patients with stage 4 chronic kidney disease and type 2 diabetes mellitus has been wit…
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: Prediabetes Stratification by Multi-omics Profile After Food Intake [NA]
A Stanford-led clinical trial on stratifying prediabetes by multi-omics after meals was withdrawn from the study registry.
-
CLINICAL_TRIALS withdrawal · 2024-12-16Clinical Trial Update: Embecta AID System in Adults With Type 2 Diabetes [NA]
A clinical trial evaluating the Embecta AID System in adults with Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-13Clinical Trial Update: Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF) [NA]
A clinical trial investigating the impact of short-term treatment with Canacardia-HF (canagliflozin) in conditions including Type 2 diabetes…
-
CLINICAL_TRIALS withdrawal · 2024-12-04Clinical Trial Update: Benefits of Nutritional Ingredients for Type 2 Diabetes [NA]
A clinical trial evaluating nutritional ingredients for type 2 diabetes was withdrawn.